Objective To estimate risk of parental cardiovascular disease mortality by offspring birthweight.
Introduction
Cardiovascular disease is an important cause of death in females. Globally, 1 of 3 women dies from cardiovascular disease 1 and the awareness of heart disease as the leading killer in women has increased during the last decades. 2 Predicting cardiovascular disease in women is difficult and the clinical presentation of the disease is often different in women compared with men. 1, 3, 4 Pregnancy has been proposed as a physiological 'stress-test' whereby a women's physiological response under the demands in pregnancy can predict long-term risk of disease. 5 If so, pregnancy complications may enable early identification of high-risk women who would benefit from preventive intervention. 6 Offspring low birthweight is a well-established predictor of parental cardiovascular disease and death. 1, [7] [8] [9] [10] [11] [12] [13] Maternal cardiovascular disease risk is highest with smaller babies, and declines by 25% with each standard deviation increase (about 500 g) in birthweight of the first child 7 with similar but weaker association among fathers. The causal pathway is not clear, and may reflect both environmental and genetic influences. Additionally, this inverse association of offspring birthweight with parental mortality may not extend across the full range of birthweights. 1 We assessed the risk of parental cardiovascular disease mortality by birthweight of offspring using linked data from population-based registries of birth and mortality in Norway, covering up to 42 years of observation. We further refined the analysis by taking gestational age into account.
Methods
The Medical Birth Registry of Norway has collected data since 1967 on all live and stillbirths from 16 weeks of gestation. Records in the registry are matched with the files of the Central Person Register, to ensure medical notification of every newborn, 14 and to collect dates of deaths. Personal identification numbers are given to every Norwegian citizen. We used these identification numbers to link fathers and mothers to their offspring, and to link parents to the Cause of Death Registry.
We included all firstborn singleton infants (of Norwegian origin) born during 1967-2002, and followed their parents through to 2009 for death due to cardiovascular causes.
Maternal and paternal causes of death were classified according to the International Classification of Diseases (ICD) (ICD-8 for 1969-85, ICD-9 for 1986-95 and ICD-10 for the years 1996-2009). We combined deaths due to ischaemic heart diseases, (I20-I25 [ICD-10], 410-414 [ICD-8 and ICD-9]) and cerebrovascular diseases/stroke (I60-I69 [ICD-10], 430-438 [ICD-8 and ICD-9]) into one entity ('cardiovascular deaths') as our main outcome variable.
Offspring birthweight was categorised into eight groups (500-999 g, 1000-1499 g, 1500-1999 g, 2000-2499 g, 2500-2999 g, 3000-3499 g, 3500-3999 g and ≥4000 g). Hazard ratios (HRs) for mothers' and fathers' cardiovascular mortality were estimated for each birthweight category, using 3000-3499 g as reference level. In addition, we used offspring birthweight as a continuous variable with a cut point at 3500 g (allowing estimation of two different trends). We then adjusted birthweight for gestational age by converting offspring birthweight into z-scores at each gestational week. All births with z-scores below À4 and above 4 were excluded from analyses as likely errors. The z-scores were categorised as À4 to À2.5, À2.5 to À1.5, À1.5 to À1, À1 to À0.5, À0.5 to 0.5, 0.5 to 1, 1 to 1.5, 1.5 to 2.5 and 2.5 to 4. HRs for parental cardiovascular death were estimated for each z-score category, using z-score 1-1.5 as reference level.
We explored possible interactions between gestational age and birth size by examining statistical significance of interaction terms. Births were stratified into preterm (22-36 weeks) and term births (>37 weeks), and grouped by gestational-age specific z-score weights into three categories: small (<À1.5), average (À1.5 to 1.5) and large (>1.5). HRs for cardiovascular mortality were estimated separately for preterm and term births, using one shared reference level (term births with z-score À1.5 to 1.5) to retain the different baseline levels of maternal mortality for preterm and term births. For women with two or more pregnancies, we also estimated the odds ratio of having diabetes in the second pregnancy, stratified on gestational age of the first infant (preterm and term) and by z-score category of the first offspring (as above).
We extended the analysis by considering parents with two heavy babies (defined as larger than the mean) in their first two pregnancies. We considered heavy weights in two categories: large (>0-2.5) and very large (z-score > 2.5). Families with two heavy babies were grouped as follows: both babies very large, first baby very large and the second large, first baby large and the second very large, and both babies large (reference category).
Hazard ratios for parental cardiovascular mortality were calculated using Cox proportional hazard models, adjusting for year of birth and parental age (categorical variable: <20 years, 20-24 years, 25-29 years, 30-34 years and >35 years). Additional adjustment for level of education had no effect on the estimates and was not included in the final models. The time variable in the Cox models was time from first birth to either death or censoring, whatever occurred first. Odds ratios for diabetes in the second pregnancy were calculated using logistic regression, adjusting for year of birth of the second child and maternal age at birth of the second child. We used SPSS, version 22.0 (IBM SPSS Statistics for Windows. Armonk, NY,USA) for all analyses.
This study was approved by the internal review board of the Medical Birth Registry of Norway and by the regional ethics committee, REK Vest, Norway (reference number: 2009/1868).
Results
Baseline characteristics of the study sample are outlined in the Supplementary material (Table S1 ). There were 711 726 mothers and 700 212 fathers included in the analysis, of whom 2279 mothers (0.3%) and 10 163 fathers (1.5%) died from cardiovascular causes during follow up. Missing information was rare in mothers (7, <0.00%) but not fathers (11 521, 1.6%), due mainly to missing information on fathers among unmarried couples. This left slightly fewer fathers for analysis. Figure 1 shows HRs for cardiovascular mortality for mothers and fathers by absolute birthweight of the first offspring. Lower birthweights were strongly associated with maternal cardiovascular mortality (HR 3.6, 95% CI 2.8-4.6 at 1000-1499 g). The association was much weaker for fathers (HR 1.3, 95% CI 1.2-1.4 at 1500-1999 g). There is no apparent association with heavy absolute birthweights.
We assessed the trends of reduced cardiovascular mortality per 500 g increase in absolute birthweight (one standard deviation is approximately 500 g). Trends were assessed separately below and above 3500 g. For every 500 g of birthweight up to 3500 g, the hazard of maternal cardiovascular death decreased by 25% (HR 0.75, 95% CI 0.71-0.78, P-trend <0.0001). There was no further increase in cardiovascular mortality above 3500 g (HR 0.96, 95% CI 0.85-1.10, P-trend = 0.57). For fathers, there was slightly improved cardiovascular mortality risk with increasing birthweights up to 3500 g (HR 0.94, 95% CI 0.91-0.96, Ptrend <0.0001), and none above 3500 g (0.99, 95% CI 0.94-1.05, P-trend = 0.70).
Women who deliver preterm are at higher risk of cardiovascular mortality. 13, 15 Hence, preterm delivery could be confounding the observed relation between offspring birthweight and mother's cardiovascular mortality risk. We therefore adjusted birthweight for gestational age by expressing birthweight in z-scores at each gestational week ( Figure 2 ). The association of offspring's low birthweight with mother's cardiovascular mortality became log-linear, and an unexpectedly strong association of very large birthweights (z-score > 2.5) with mother's cardiovascular mortality emerged (HR 3.0, 95% CI 2.0-4.6).
We further stratified these analyses on total number of lifetime pregnancies (1 or 2+), using the z-score 1-1.5 within each stratum as reference. Women having one lifetime pregnancy are an established risk group for cardiovascular death later in life. 16, 17 In our data, these women had a 2.5-fold risk of cardiovascular death compared with women with two or more births. Risk patterns were similar by z-score birthweights in both strata. In mothers with only one lifetime pregnancy and a very large baby the hazard ratio was 2.6 (95% CI 1.4-5.1). With two or more pregnancies and a very large baby in the first, the hazard ratio was 3.0 (95% CI 1.8-5.2). The same adjustments for gestational age had no effect on father's cardiovascular mortality (Figure 2 ). We explored this unexpected association in mothers by stratifying the analysis by preterm and term births (Figure 3) . A striking interaction emerged: very large term babies had no adverse association with mother's cardiovascular mortality (HR 0.9, 95% CI 0.7-1.2), whereas very large preterm babies were associated with higher cardiovascular mortality (HR 1.5, 95% CI 1.03-2.2; P-value for interaction = 0.02). When using a single reference for both groups (z-score À1.5 to 1.5 for all births), mothers' hazard ratio for cardiovascular mortality with large babies was 3.8 (95% CI 2.3-6.3) with preterm babies, but null with term babies (0.9, 95% CI 0.7-1.2). In additional analyses we adjusted the results by maternal level of education; these patterns did not change.
One possibility for the high maternal cardiovascular mortality risk after birth of a large preterm baby could be the presence of maternal conditions, such as diabetes, that predispose for both heavy fetuses and preterm delivery, and also increase the mother's later cardiovascular disease risk. We explored this possibility in a sub-analysis in women having more than one birth by calculating the risk that a mother with a large first birth will develop diabetes in her next pregnancy (Figure 4 ). There was a marked increase in risk of diabetes after large babies (zscore > 1.5), regardless of whether the first pregnancy was term or preterm.
We considered the association of repeated large babies on later maternal cardiovascular mortality. The hazard ratio for cardiovascular death in women having two very large babies (z-score > 2.5) was 8.5 (95% CI 3.5-20.7), compared with women having two babies with z-scores ≥0-2.5. Mothers' cardiovascular mortality was less if only the first baby was very large (HR 3.4, 95% CI 1.8-6.4) or if only the second baby was very large (HR 1.8, 95% CI 0.99-3.2).
Discussion

Main findings
Mothers whose first baby was very large (gestational-ageadjusted z-score > 2.5) were at increased risk of cardiovascular mortality. This risk was especially high among women whose first two babies were both very large. Women who Odds ratios with 95% CI for diabetes in the second pregnancy by z-score by birthweight categories (<À1.5, À1.5 to 1.5 and >1.5) of singleton first offspring born preterm and term in Norway (1967 Norway ( -2002 . Estimates were adjusted for year of birth of the second child and maternal age at second birth; z-score was limited to À4 to +4 (35 008 and 567 116 mothers, respectively).
gave birth to a very large preterm infant were at increased risk of both subsequent diabetes and cardiovascular mortality. With term babies, the association was strong for diabetes, but apparently absent for cardiovascular mortality risk.
We confirm previous findings of increased cardiovascular mortality risk among parents of small birthweights but not larger birthweights, based on absolute weights (Figure 1) . 7, 9, 10, 12, 13, 18 However, when using gestationalage-standardised birthweights, an increase in maternal cardiovascular mortality emerges for larger birthweights (Figure 2 ). This association of maternal cardiovascular mortality risk has been suggested by others, 19, 20 but results have been conflicting, especially when using absolute birthweights. 7, 13, 18, 21, 22 Our analysis shows that maternal cardiovascular mortality risk is inflated at the lower end of the absolute birthweight range by the inclusion of preterm births. The use of unadjusted birthweights also distorts the association of maternal cardiovascular mortality after larger offspring. Preterm babies <3500 g can end up in the 'lower' birthweight range even if they are large or very large for gestational age. With preterm babies the crucial metric is not smallness in absolute terms, but heaviness for their gestational age. The use of absolute birthweights in previous studies has missed the risk of maternal cardiovascular death associated with preterm babies who are large for gestational age. Babies above a z-score of 1.5 are more frequent among preterm first births (13%) than term first births (3%) (Pvalue difference <0.0001). The interaction between gestational age and z-score for large preterm babies emphasises the importance of relative growth, and suggests that the association of relatively large birthweights with maternal cardiovascular mortality is more important in preterm than in term infants.
Strengths and limitations
Strengths of the study include its use of a large national cohort of women with complete prospective registration of exposures and outcomes, with scant missing information. The data provide mortality follow up for up to 42 years after the first birth, with a median follow up of 25 years. Additionally, the use of sibling files allows assessment of having repeated large babies, which is associated with even higher maternal risk. The use of standardised birthweight (gestational-age-adjusted birthweight z-scores) becomes crucial when assessing the link between offspring birthweight and maternal cardiovascular mortality.
Limitations of this study include a lack of data on underlying cardiovascular risk factors before and after pregnancy, and information on important co-variates such as body mass index and smoking. However, smoking is an established risk factor for having small-for-gestational age infants. 23 It is likely that adjusting for smoking would have further enhanced our risk estimates for larger babies.
Interpretation
Our analyses show a strong association of large offspring birthweight with maternal cardiovascular mortality when adjusting for gestational age (by z-score). This association was striking with preterm babies but apparently absent with term births. Absolute birthweight, most commonly used in previous studies, masks these risks. Our data confirm previous reports of weak associations between low offspring birthweight and father's cardiovascular mortality.
Previous studies have shown a strong association of preterm delivery with maternal cardiovascular mortality. 13, 15 We find that this effect is not mediated only through small babies, but is also important for large preterm babies. We are not sure how to interpret the absence of an association of large term babies with maternal cardiovascular mortality ( Figure 3) . Given that mothers' risk of diabetes in a subsequent pregnancy is equally elevated with relatively large first birth-regardless of gestational age-the lack of an association of large term weights with mothers' cardiovascular mortality risk may not convey the complete picture. Longer follow up of maternal deaths may show a different pattern.
The physiological demands of pregnancy offer an early life 'stress-test' that may uncover latent cardiovascular mortality risk in women. Our study shows that gestational-ageadjusted small and large birthweights are markers of such latent risk, especially with preterm births.
Conclusion
Women giving birth to a large preterm baby are at increased risk of both diabetes and long-term cardiovascular mortality. The association between increasing offspring birthweight and reduced maternal cardiovascular mortality is not linear across the birthweight range, particularly within preterm births. The birth of a large preterm baby should increase clinical vigilance for onset of diabetes and other possible cardiovascular mortality risk factors.
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